France’s Mayoly Spindler Set To Acquire Ipsen’s Consumer Business

Mayoly Spindler is stepping up its presence in the self-care market with the acquisition of Ipsen's Consumer Healthcare business, which has been under strategic review for the past year.

MT1809_Hand Shake_529519042_1200.jpg
• Source: Shuttestock

Laboratoires Mayoly Spindler is taking a significant step towards its goal of becoming a top-10 OTC player in Europe with the acquisition of Ipsen’s Consumer Healthcare business.

Paris, France-based Ipsen has entered into exclusive negotiations with privately held Mayoly Spindler to sell the Consumer Healthcare operation in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

Navamedic Adds OTC Naloxone With DNE Pharma Acquisition

 
• By 

Norway's Navamedic will move into the addiction treatment market with the acquisition of DNE Pharma, adding to its portfolio an OTC opioid overdose reversal spray.

AESGP Annual Meeting: Consumer Health Sector Still Safe Bet For Investors

 
• By 

A healthy diversity of different types of players and plenty of space for scaling up are among the reasons that investors remain interested in the consumer health sector, according to investment bankers speaking at the recent AESGP Annual Meeting.

Germany’s PharmaSGP To Be Taken Private

 
• By 

Consumer health player PharmaSGP will be taken private by its biggest shareholder, FUTRUE.

Alliance Pharma’s New Owners Will Instill ‘More Consumer-Oriented Mindset’

 
• By 

Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.

More from Business

P&G’s Crest Gum Detoxify Ad Claims Rinsed Clean In NAD Review On GuruNanda Challenge

 

P&G provided sufficient support for all challenged claims, including the “Gum Detoxify” brand used on the product label and in advertising on the website and in magazine detail pages.

Moberg Nail Fungus Line Takes Lead In Norway As Firm Plots EU Expansion

 
• By 

Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By 

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.